Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria

scientific article published on 30 September 2006

Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1000923461
P356DOI10.1245/S10434-006-9188-4
P698PubMed publication ID17013685

P2093author name stringHsuan-Ying Huang
Hock-Liew Eng
Chien-Feng Li
Shau-Hsuan Li
Ching-Nan Lin
David Lu
Shih-Chen Yu
Ching-Yeh Hsiung
Wen-Wei Huang
P2860cites workPreventing re-replication of chromosomal DNA.Q24653685
Differentiation and risk assessment of gastrointestinal stromal tumorsQ40567244
P433issue12
P921main subjectimmunohistochemistryQ899285
P304page(s)1633-1644
P577publication date2006-09-30
P1433published inAnnals of Surgical OncologyQ2853069
P1476titleImmunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria
P478volume13

Reverse relations

cites work (P2860)
Q55055264Clinical proteomics identified ATP-dependent RNA helicase DDX39 as a novel biomarker to predict poor prognosis of patients with gastrointestinal stromal tumor
Q53762409Clinicopathologic analysis of gastrointestinal stromal tumors in duodenum and small intestine
Q34193040Clinicopathological and Immunohistochemical Features of Gastointestinal Stromal Tumors
Q35220032Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis
Q42079126Does Immunohistochemistry for Discovered on GIST1 and Minichromosome Maintenance Protein7 Provide Additional Clinicopathological Value in Gastrointestinal Stromal Tumors?
Q37072355Drug Insight: gastrointestinal stromal tumors (GIST)--the solid tumor model for cancer-specific treatment
Q38039758Duodenal gastrointestinal stromal tumors: Review on clinical and surgical aspects
Q35988533Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors
Q44457599Exon 11 mutations, Ki67, and p16INK4A as predictors of prognosis in patients with GIST
Q39817880Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location
Q33695315High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors
Q47929181HuR cytoplasmic expression is associated with increased cyclin A expression and inferior disease-free survival in patients with gastrointestinal stromal tumours (GISTs).
Q89929998KIF15 Expression in Tumor-associated Monocytes Is a Prognostic Biomarker in Hepatocellular Carcinoma
Q34183218Loss of chromosome 9p21 and decreased p16 expression correlate with malignant gastrointestinal stromal tumor
Q53307455MCM-2 and MCM-5 expression in gastric adenocarcinoma: clinical significance and comparison with Ki-67 proliferative marker.
Q83816731Minichromosome maintenance (MCM) and AgNOR proteins expression in desmoid tumours: a tissue microarray analysis
Q37222003Progesterone receptor does not improve the performance and test effectiveness of the conventional 3-marker panel, consisting of estrogen receptor, vimentin and carcinoembryonic antigen in distinguishing between primary endocervical and endometrial a
Q35886697Prognostic significance of PTEN, Ki-67 and CD44s expression patterns in gastrointestinal stromal tumors
Q38071053Proteomic approach toward personalized sarcoma treatment: Lessons from prognostic biomarker discovery in gastrointestinal stromal tumor
Q34407270Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib.
Q37166460Scoring mechanisms of p16INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue micro
Q45249023Scoring of p16(INK4a) immunohistochemistry based on independent nuclear staining alone can sufficiently distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study
Q36897784p16 expression differentiates high-risk gastrointestinal stromal tumor and predicts poor outcome

Search more.